Novel treatment approaches utilizing antibody-drug conjugates in breast cancer

Abstract Antibody-drug conjugates (ADCs) are rapidly changing the way we treat patients with breast cancer. Despite this progress, many unanswered questions remain regarding the sequencing of different ADCs with similar payloads, optimal combinations, drug design strategies to limit off-target toxic...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew A. Davis, Jennifer Hesse, Patrícia M. R. Pereira, Cynthia X. Ma
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-025-00743-w
Tags: Add Tag
No Tags, Be the first to tag this record!